Aurobindo Pharma Unit Receives US FDA Warning Letter; No Impact on US Supplies
Aurobindo Pharma’s Eugia Pharma Specialities has received a US FDA warning letter for its Telangana facility, while the company said existing US supplies remain unaffected.
Eugia Pharma Specialities | 14/08/2026 | By News Bureau | 200
Aurobindo Pharma's Eugia Unit I Receives US FDA Warning Letter
Aurobindo Pharma’s Eugia Pharma Unit I receives a US Food and Drug Administration (FDA) Warning Letter following OAI status, with no impact on existing US supplies.
Eugia Pharma Specialities | 14/08/2026 | By News Bureau | 242
Aurobindo Pharma Approves Merger of Eugia Subsidiaries to Streamline Business Operations
Aurobindo Pharma has approved the merger of two step-down subsidiaries into Eugia Pharma Specialities, a move aimed at consolidating similar businesses, reducing administrative costs and strengthening operational efficiency.
Eugia Pharma Specialities | 07/08/2026 | By News Bureau | 157
US FDA Classifies Aurobindo Pharma's Eugia Unit-III Inspection as Official Action Indicated
Aurobindo Pharma said the US FDA has classified its inspection of Eugia Unit-III in Telangana as Official Action Indicated, while reaffirming its commitment to maintaining global quality manufacturing standards.
Eugia Pharma Specialities | 16/06/2026 | By News Bureau | 270
Eugia Pharma Gets FDA Approval for Pazopanib Tablets
Aurobindo Pharma has announced that its wholly owned subsidiary company, Eugia Pharma Specialities, has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Pazopanib Tablets, 200 mg.
Eugia Pharma Specialities | 06/12/2024 | By Aishwarya | 395
Aurobindo's subsidiary Eugia Pharma Specialities receives final approval from US FDA
Aurobindo's subsidiary Eugia Pharma Specialities receives final approval from US FDA to manufacture, market cancer drug Lenalidomide caps
Eugia Pharma Specialities | 11/03/2023 | By Sudeep Soparkar | 1752
Aurobindo Pharma's arm Eugia Pharma Specialities bags
This is a partnership product from TTY Biopharm Company and will be manufactured at the Taiwan facility
Eugia Pharma Specialities | 18/11/2022 | By Sudeep Soparkar | 1283
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy